Journal of Vascular Surgery
Volume 51, Issue 1 , Pages 184-193 , January 2010

Antioxidant therapy reverses impaired graft healing in hypercholesterolemic rabbits

Presented as the American Vascular Association (AVA) Resident Research Prize Paper at the Sixty-third annual meeting of the Society for Vascular Surgery, Denver, Colo, Jun 11-14, 2009.

  • Michael A. Rosenbaum, MD

      Affiliations

    • Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio
    • Department of Surgery, University Hospitals of Cleveland, Cleveland, Ohio
    • ,
  • Keiko Miyazaki, MD

      Affiliations

    • Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Scott M. Colles

      Affiliations

    • Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Linda M. Graham, MD

      Affiliations

    • Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio
    • Department of Vascular Surgery, Cleveland Clinic, Cleveland, Ohio
    • Corresponding Author InformationCorrespondence: Linda M. Graham, MD, Cleveland Clinic, Department of Biomedical Engineering/ND20, 9500 Euclid Ave, Cleveland, OH 44195

Received 27 May 2009 ,Accepted 15 August 2009.

References 

  1. Allison MA, Ho E, Denenberg JO, Langer RD, Newman AB, Fabsitz RR, et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prevent Med. 2007;32:328–333
  2. Yao E-H, Yu Y, Fukuda N. Oxidative stress on progenitor and stem cells in cardiovascular diseases. Curr Pharmaceut Biotechnol. 2006;7:101–108
  3. Baumann DS, Doblas M, Daugherty A, Sicard G, Schonfeld G. The role of cholesterol accumulation in prosthetic vascular graft anastomotic intimal hyperplasia. J Vasc Surg. 1994;19:435–445
  4. Murugesan G, Chisolm GM, Fox PL. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J Cell Biol. 1993;120:1011–1019
  5. Chatterjee S. Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation. Mol Cell Biochem. 1992;111:143–147
  6. Absood A, Furutani A, Kawamura T, Graham LM. Differential PDGF secretion by graft and aortic SMC in response to oxidized LDL. Am J Physiol Heart Circ Physiol. 2002;283:H725–H732
  7. Absood A, Furutani A, Kawamura T, Graham LM. A comparison of oxidized LDL-induced collagen secretion by graft and aortic SMCs: role of PDGF. Am J Physiol Heart Circ Physiol. 2004;287:H1200–H1206
  8. van Aalst JA, Pitsch RJ, Absood A, Fox PL, Graham LM. Mechanism of Dacron-activated monocytic cell oxidation of low density lipoprotein. J Vasc Surg. 2000;31:171–180
  9. van Aalst JA, Fox PL, Graham LM. Lipid oxidation products in implanted vascular grafts. Surg Forum. 1998;49:324–326
  10. Miyazaki K, Colles SM, Graham LM. Impaired graft healing due to hypercholesterolemia is prevented by dietary supplementation with a-tocopherol. J Vasc Surg. 2008;48:986–993
  11. Campeau L, Enjalbert M, Lespérance J, Bourassa MG, Kwiterovich P, Wacholder S, et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. N Engl J Med. 1984;311:1329–1332
  12. Abu Rahma AF, Robinson PA, Stuart SP, Witsberger TA, Stewart WA, Boland JP. Polytetrafluoroethylene grafts in infrainguinal arterial revascularization (Factors affecting outcome). Arch Surg. 1993;128:417–422
  13. van Aalst JA, Zhang D-M, Miyazaki K, Colles SM, Fox PL, Graham LM. Role of reactive oxygen species in inhibition of endothelial cell migration by oxidized low-density lipoprotein. J Vasc Surg. 2004;40:1208–1215
  14. Kappert K, Sparwel J, Sandin Å, Seiler A, Siebolts U, Leppänen O, et al. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Arterioscler Thromb Vasc Biol. 2006;26:2644–2651
  15. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6:593–597
  16. Witko-Sarsat V, Gausson V, Nguyen A-T, Touam M, Drüeke T, Santangelo F, et al. AOPP-induced activation of human nuetrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int. 2003;64:82–91
  17. Mc Namara JR, Huang C, Massov T, Leary ET, Warnick GR, Rubins HB, et al. Modification of the dextran-Mg2+ high-density lipoprotein cholesterol precipitation method for use with previously frozen plasma. Clin Chem. 1994;40:233–239
  18. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med. 1976;15:212–216
  19. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–917
  20. Goh EH, Krauth DK, Colles SM. Analysis of cholesterol and desmosterol in cultured cells without organic solvent extraction. Lipids. 1990;25:738–741
  21. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381–1478
  22. Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, et al. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med. 2006;203:1117–1127
  23. Tardif J-C, Côté G, Lespérance J, Bourassa M, Lambert J, Doucet S, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med. 1997;337:365–372
  24. Daida H, Kuwabara Y, Yokoi H, Nishikawa H, Takatsu F, Nakata Y, et al. Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART]). Am J Cardiol. 2000;86:550–552A9
  25. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Ciccolo A, Centorrino T, et al. Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat. FASEB J. 2001;15:1187–1200
  26. Geudens N, Van De Wauwer C, Neyrinck AP, Timmermans L, Vanhooren HM, Vanaudenaerde BM, et al. N-acetyl cysteine pre-treatment attenuates inflammatory changes in the warm ischemic murine lung. J Heart Lung Transplant. 2007;26:1326–1332
  27. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-k B. Annu Rev Cell Biol. 1994;10:405–455
  28. Hayashi K, Takahata H, Kitagawa N, Kitange G, Kaminogo M, Shibata S. N-acetylcysteine inhibited nuclear factor-k B expression and the intimal hyperplasia in rat carotid arterial injury. Neurol Res. 2001;23:731–738
  29. Lau AK, Leichtweis SB, Hume P, Mashima R, Hou JY, Chaufour X, et al. Probucol promotes functional reendothelialization in balloon-injured rabbit aortas. Circulation. 2003;107:2031–2036
  30. Johansson J, Olsson AG, Bergstrand L, Elinder LS, Nilsson S, Erikson U, et al. Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia (A Probucol Quantitative Regression Swedish Trial (PQRST) report). Arterioscler Thromb Vasc Biol. 1995;15:1049–1056
  31. Murugesan G, Sa G, Fox PL. High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor. Circ Res. 1994;74:1149–1156
  32. Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, Chambliss KL, et al. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res. 2006;98:63–72
  33. Mass H, Pirazzi B, Gonzalez P, Collazo V, Fitzovich D, Avakian E. N-acetylcysteine diminishes injury induced by balloon angioplasty of the carotid artery in rabbits. Biochem Biophys Res Commun. 1995;215:613–618
  34. Ghigliotti G, Mereto E, Eisenberg PR, Martelli A, Orsi P, Sini D, et al. N-acetyl-cysteine reduces neointimal thickening and procoagulant activity after balloon-induced injury in abdominal aortae of New Zealand White rabbits. Thromb Haemost. 2001;85:724–729
  35. Tanous D, Bräsen JH, Choy K, Wu BJ, Kathir K, Lau A, et al. Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization. Atherosclerosis. 2006;189:342–349
  36. Baumann DS, Doblas M, Schonfeld G, Sicard GA, Daugherty A. Probucol reduces the cellularity of aortic intimal thickening at anastomotic regions adjacent to prosthetic grafts in cholesterol-fed rabbits. Arterioscler Thromb. 1994;14:162–167
  37. Miyauchi K, Aikawa M, Tani T, Nakahara K, Kawai S, Nagai R, et al. Effect of probucol on smooth muscle cell proliferation and dedifferentiation after vascular injury in rabbits: possible role of PDGF. Cardiovasc Drugs Ther. 1998;12:251–260
  38. Deutsch M, Meinhart J, Zilla P, Howanietz N, Gorlitzer M, Froeschl A, et al. Long-term experience in autologous in vitro endothelialization of infrainguinal e-PTFE grafts. J Vasc Surg. 2009;49:352–362
  39. Formichi MJ, Guidoin RG, Jausseran JM, Awad JA, Johnston KW, King MW, et al. Expanded PTFE prostheses as arterial substitutes in humans: Late pathological findings in 73 excised grafts. Ann Vasc Surg. 1998;2:14–27
  40. Meinhart J, Deutsch M, Zilla P. Eight years of clinical endothelial cell transplantation (Closing the gap between prosthetic grafts and vein grafts). ASAIO J. 1997;43:M515–M521

 This project was supported by National Heart, Lung, Blood Institute grants HL41187, HL64357, and F32HL090205.

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)01780-7

doi: 10.1016/j.jvs.2009.08.061

Journal of Vascular Surgery
Volume 51, Issue 1 , Pages 184-193 , January 2010

Article Tools

* Image Usage & Resolution